Like almost any other industry, emerging technologies are constantly changing what is possible within antibody engineering and therapeutics. AI and computational learning alone has the potential to revolutionize the field in the next decade, whilst emerging global economies could change the landscape by 2030.
Over the following pages, we explore what the future of the field looks like over the coming decade, delving into the latest technologies, platforms and strategies and making predictions for what impact they are going to have.
